What’s the hype about Pharmacogenomics
In this interview, Bryn Williams-Jones comments on the hype surrounding pharmacogenomics: the financial opportunities and risks faced by the industry and governments, the promises to the patients and the issues of accessibility and ethics.
Bryn Williams-Jones on the hype in pharmacogenomics
|Guest :||Bryn Williams-Jones, Ph.D.|
|Journalist :||Helena Urfer, M.Sc.|